The anti-coagulant drug Xarelto® has been implicated in thousands of instances of uncontrollable internal bleeding, and hundreds of deaths. Unlike some other blood thinners, there is no cure—no antidote for the bleeding. Hemorrhaging patients must be hospitalized and simply hope the drug wears off soon enough.
Xarelto® Has Been Linked to Uncontrollable Internal Hemorrhaging
Bayer Pharmaceuticals and Johnson & Johnson, the pharmaceutical companies who developed and marketed the prescription drug, Xarelto (Rivaroxaban), have been blamed for failing to warn patients of a very serious and adverse side effect of this drug: uncontrollable bleeding.
Since the product was approved by the FDA in July 2011, doctors have been reporting thousands of adverse events, including internal bleeding, hospitalization, disability and death.
According to Adverse Events, the company who compiles the physician data obtained through the FDA Adverse Events Reporting System (FAERS), Xarelto has been considered the “primary suspect” in over 1,821 reports filed in FAERS as of August 27, 2012. These adverse events include gastrointestinal hemorrhage, brain hemorrhage, thrombosis, hematoma, edema peripheral and dyspnea and hemoglobin decrease. Hospitalization was reported in 891 of these events; 183 patients died from the medication.
Xarelto Is Prescribed As An Anti-Coagulant
Xarelto has been prescribed by doctors for three main reasons: (1) to reduce the risk of blood clots and strokes in patients with atrial fibrillation; (2) to treat deep vein thrombosis and pulmonary embolism; and to reduce the risk of clotting in patients who had hip or knee replacement surgery.
Xarelto is a blood thinner that prevents the clotting of blood. Blood clotting is essential to stop bleeding from a wound, but some people have conditions where they bleed even when they’re not injured. For instance, patients with atrial fibrillation are prescribed Xeralto to prevent the blood from pooling in the heart. This aids in preventing blood clots from travelling to the brain and causing the patient to have a stroke. Deep vein thrombosis (blood clots in the legs) and pulmonary embolism (blood clots in the lungs) can possibly lead to death if untreated.
To date there is no antidote to stop the uncontrollable bleeding caused by Xeralto. Instead, patients have to wait until the effects of the drug have subsided. This waiting game can lead to hospitalization, disability and even death.
Xarelto is licensed from Bayer Healthcare AG and is marketed by Janssen Pharmaceuticals, a Johnson & Johnson company. None of these companies have warned consumers about the uncontrollable bleeding that may occur from taking Xeralto. In fact, the FDA has asked the pharmaceutical companies to conduct further studies in order to test Xeralto’s safety. Those studies have yet to be completed.
Call Us Now For a Free and Confidential Consultation
If you or a loved one were prescribed Xarelto and suffered internal bleeding, please contact us at (855) 480-6881, or use the contact form or chat button on this page for a free and confidential consultation.
Our national team of lawyers has seen tremendous success in representing victims just like you. We have the resources and experience you need to take on pharmaceutical giants like Bayer Healthcare and Johnson & Johnson. We hold the drug companies accountable for their negligence. Our results speak for themselves.
Our firm works on a contingency fee basis only, which means there is no cost to you unless we settle your case. You pay ZERO out-of-pocket costs unless we win.
Call us NOW at (855) 480-6881 for a free case evaluation. We’re available 24/7 to answer your questions and address your concerns.
Please consult your physician prior to stopping any medication.